In the present study, we have revealed that co-treatment of MDA-MB-231 breast cancer cells with MOXI and MIM1 resulted in apoptosis intensification, expressed as mitochondrial membrane potential breakdown and induction of DNA fragmentation. Here, MIMT1 is linked to breast carcinoma.